ESGVH (ESCMID Study Group for Viral Hepatitis)
@esgvh.bsky.social
ESGVH is ESCMID's Study Group for Viral Hepatitis. Committed to collaborative excellence in the field of viral hepatitis.
Honoured and proud that our Chair, Prof. @oana-sandulescu.bsky.social delivered a fantastic keynote at #ESCV2026 in Porto!
“Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions.
#HIV #HBV
@escvirology.bsky.social
@escmid.bsky.social
“Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions.
#HIV #HBV
@escvirology.bsky.social
@escmid.bsky.social
September 18, 2026 at 3:12 PM
Honoured and proud that our Chair, Prof. @oana-sandulescu.bsky.social delivered a fantastic keynote at #ESCV2026 in Porto!
“Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions.
#HIV #HBV
@escvirology.bsky.social
@escmid.bsky.social
“Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions.
#HIV #HBV
@escvirology.bsky.social
@escmid.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Friday morning = keynote time at #ESCV2026 in Porto!
My keynote: Practical ART decision-making in HIV-HBV coinfection
4 patient trajectories
4 ART decisions
4 things to know
The message? HBV matters.
Thank you @escvirology.bsky.social 👏👏
@esgvh.bsky.social
@escmid.bsky.social
My keynote: Practical ART decision-making in HIV-HBV coinfection
4 patient trajectories
4 ART decisions
4 things to know
The message? HBV matters.
Thank you @escvirology.bsky.social 👏👏
@esgvh.bsky.social
@escmid.bsky.social
September 18, 2026 at 8:55 AM
Friday morning = keynote time at #ESCV2026 in Porto!
My keynote: Practical ART decision-making in HIV-HBV coinfection
4 patient trajectories
4 ART decisions
4 things to know
The message? HBV matters.
Thank you @escvirology.bsky.social 👏👏
@esgvh.bsky.social
@escmid.bsky.social
My keynote: Practical ART decision-making in HIV-HBV coinfection
4 patient trajectories
4 ART decisions
4 things to know
The message? HBV matters.
Thank you @escvirology.bsky.social 👏👏
@esgvh.bsky.social
@escmid.bsky.social
⏰ TIME TO REGISTER!
🌍 Major international experts in viral hepatitis - all in one place.
Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases.
📅 27–29 Nov 2026 | 💻 Online
👉 Register now lnkd.in/e53ChGBN
@escmid.bsky.social
🌍 Major international experts in viral hepatitis - all in one place.
Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases.
📅 27–29 Nov 2026 | 💻 Online
👉 Register now lnkd.in/e53ChGBN
@escmid.bsky.social
September 13, 2026 at 11:04 AM
⏰ TIME TO REGISTER!
🌍 Major international experts in viral hepatitis - all in one place.
Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases.
📅 27–29 Nov 2026 | 💻 Online
👉 Register now lnkd.in/e53ChGBN
@escmid.bsky.social
🌍 Major international experts in viral hepatitis - all in one place.
Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases.
📅 27–29 Nov 2026 | 💻 Online
👉 Register now lnkd.in/e53ChGBN
@escmid.bsky.social
Starting in 3 hours!
Join us:
HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps
📅 10 September 2026
⏰ 3 pm CEST
💻 Zoom
🔗 Participation is free.
Register here:
lnkd.in/e577hvey
@aasldnews.bsky.social
@idsainfo.bsky.social
@inhsu.bsky.social
@escmid.bsky.social
Join us:
HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps
📅 10 September 2026
⏰ 3 pm CEST
💻 Zoom
🔗 Participation is free.
Register here:
lnkd.in/e577hvey
@aasldnews.bsky.social
@idsainfo.bsky.social
@inhsu.bsky.social
@escmid.bsky.social
September 10, 2026 at 10:25 AM
Starting in 3 hours!
Join us:
HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps
📅 10 September 2026
⏰ 3 pm CEST
💻 Zoom
🔗 Participation is free.
Register here:
lnkd.in/e577hvey
@aasldnews.bsky.social
@idsainfo.bsky.social
@inhsu.bsky.social
@escmid.bsky.social
Join us:
HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps
📅 10 September 2026
⏰ 3 pm CEST
💻 Zoom
🔗 Participation is free.
Register here:
lnkd.in/e577hvey
@aasldnews.bsky.social
@idsainfo.bsky.social
@inhsu.bsky.social
@escmid.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
ICYMI: New online! Reply to ‘Closing the policy gap: including children in the global agenda for steatotic liver disease’
Reply to ‘Closing the policy gap: including children in the global agenda for steatotic liver disease’
Nature Reviews Gastroenterology & Hepatology, Published online: 26 August 2026; doi:10.1038/s41575-026-01252-2Reply to ‘Closing the policy gap: including children in the global agenda for steatotic liver disease’
dlvr.it
September 1, 2026 at 9:10 AM
ICYMI: New online! Reply to ‘Closing the policy gap: including children in the global agenda for steatotic liver disease’
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
A thought to carry into autumn 🍂
At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly.
A great example of ID&cardio shared responsibility for the same patient.
Flu prevention is also CV prevention 💉❤️
@escardio.bsky.social
@medscape.com
At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly.
A great example of ID&cardio shared responsibility for the same patient.
Flu prevention is also CV prevention 💉❤️
@escardio.bsky.social
@medscape.com
September 1, 2026 at 6:12 PM
A thought to carry into autumn 🍂
At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly.
A great example of ID&cardio shared responsibility for the same patient.
Flu prevention is also CV prevention 💉❤️
@escardio.bsky.social
@medscape.com
At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly.
A great example of ID&cardio shared responsibility for the same patient.
Flu prevention is also CV prevention 💉❤️
@escardio.bsky.social
@medscape.com
Breakthroughs in #ViralHepatitis begin with shared commitment.
Read below an excellent paper published in #Germs_MDPI by our valued #ESGVH EC leaders: Prof @oana-sandulescu.bsky.social, Prof M Maticic, Assoc Prof I Hasanoglu.
👉 brnw.ch/21x4vKJ
@escmid.bsky.social
#WorldHepatitisDay
Read below an excellent paper published in #Germs_MDPI by our valued #ESGVH EC leaders: Prof @oana-sandulescu.bsky.social, Prof M Maticic, Assoc Prof I Hasanoglu.
👉 brnw.ch/21x4vKJ
@escmid.bsky.social
#WorldHepatitisDay
July 29, 2026 at 10:05 AM
Breakthroughs in #ViralHepatitis begin with shared commitment.
Read below an excellent paper published in #Germs_MDPI by our valued #ESGVH EC leaders: Prof @oana-sandulescu.bsky.social, Prof M Maticic, Assoc Prof I Hasanoglu.
👉 brnw.ch/21x4vKJ
@escmid.bsky.social
#WorldHepatitisDay
Read below an excellent paper published in #Germs_MDPI by our valued #ESGVH EC leaders: Prof @oana-sandulescu.bsky.social, Prof M Maticic, Assoc Prof I Hasanoglu.
👉 brnw.ch/21x4vKJ
@escmid.bsky.social
#WorldHepatitisDay
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Effective solutions to control viral hepatitis already exist, including vaccination, harm reduction, testing and treatment.
This #WorldHepatitisDay, the challenge is ensuring these life-saving interventions are accessible to everyone who needs them.
bit.ly/WorldHepDay2026
#IDsky #EpiSky
This #WorldHepatitisDay, the challenge is ensuring these life-saving interventions are accessible to everyone who needs them.
bit.ly/WorldHepDay2026
#IDsky #EpiSky
July 28, 2026 at 6:25 AM
Effective solutions to control viral hepatitis already exist, including vaccination, harm reduction, testing and treatment.
This #WorldHepatitisDay, the challenge is ensuring these life-saving interventions are accessible to everyone who needs them.
bit.ly/WorldHepDay2026
#IDsky #EpiSky
This #WorldHepatitisDay, the challenge is ensuring these life-saving interventions are accessible to everyone who needs them.
bit.ly/WorldHepDay2026
#IDsky #EpiSky
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
But gaps remain:
➡️ Hepatitis B vaccination coverage uneven across the EU/EEA
➡️ access to harm reduction services for people who inject drugs remains inadequate in many countries.
Annual epidemiological report on Hepatitis B:
www.ecdc.europa.eu/en/publicati...
#Hepatitis #HepatitisB #HepatitisC
➡️ Hepatitis B vaccination coverage uneven across the EU/EEA
➡️ access to harm reduction services for people who inject drugs remains inadequate in many countries.
Annual epidemiological report on Hepatitis B:
www.ecdc.europa.eu/en/publicati...
#Hepatitis #HepatitisB #HepatitisC
Hepatitis B - Annual Epidemiological Report for 2024
For 2024, 30 EU/EEA countries reported 37 605 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 7.5 cases per 100 000 population.
www.ecdc.europa.eu
July 28, 2026 at 6:25 AM
But gaps remain:
➡️ Hepatitis B vaccination coverage uneven across the EU/EEA
➡️ access to harm reduction services for people who inject drugs remains inadequate in many countries.
Annual epidemiological report on Hepatitis B:
www.ecdc.europa.eu/en/publicati...
#Hepatitis #HepatitisB #HepatitisC
➡️ Hepatitis B vaccination coverage uneven across the EU/EEA
➡️ access to harm reduction services for people who inject drugs remains inadequate in many countries.
Annual epidemiological report on Hepatitis B:
www.ecdc.europa.eu/en/publicati...
#Hepatitis #HepatitisB #HepatitisC
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
No one should die from a disease that is preventable, diagnosable and treatable.
Yet around 5M people in Europe live with chronic hepatitis B or C, and almost 60,000 people die each year from liver disease linked to these infections.
More information about the situation: bit.ly/WorldHepDay2026
Yet around 5M people in Europe live with chronic hepatitis B or C, and almost 60,000 people die each year from liver disease linked to these infections.
More information about the situation: bit.ly/WorldHepDay2026
World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
While Europe has made steady progress in preventing hepatitis B and C the region is set to miss the 2030 target to eliminate viral hepatitis as a public health threat.
bit.ly
July 28, 2026 at 6:25 AM
No one should die from a disease that is preventable, diagnosable and treatable.
Yet around 5M people in Europe live with chronic hepatitis B or C, and almost 60,000 people die each year from liver disease linked to these infections.
More information about the situation: bit.ly/WorldHepDay2026
Yet around 5M people in Europe live with chronic hepatitis B or C, and almost 60,000 people die each year from liver disease linked to these infections.
More information about the situation: bit.ly/WorldHepDay2026
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
On #WorldHepatitisDay we celebrate many advances created through partnership between science & healthcare across continents… while continuing to advocate for urgent action, resources & data.
@whowpro.bsky.social @crick.ac.uk
@worldhepalliance.bsky.social @ahri-news.bsky.social
#MedSky #LiverSky 🧪
@whowpro.bsky.social @crick.ac.uk
@worldhepalliance.bsky.social @ahri-news.bsky.social
#MedSky #LiverSky 🧪
July 28, 2026 at 2:53 PM
On #WorldHepatitisDay we celebrate many advances created through partnership between science & healthcare across continents… while continuing to advocate for urgent action, resources & data.
@whowpro.bsky.social @crick.ac.uk
@worldhepalliance.bsky.social @ahri-news.bsky.social
#MedSky #LiverSky 🧪
@whowpro.bsky.social @crick.ac.uk
@worldhepalliance.bsky.social @ahri-news.bsky.social
#MedSky #LiverSky 🧪
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Missed our first #WorldHepatitisDay webinar?
Watch it back and download our new community briefing to understand the latest global hepatitis data and how we can accelerate action.
Watch back the webinar here: https://bit.ly/4vZCQg0
Download the briefing: https://bit.ly/4y45pdA
Watch it back and download our new community briefing to understand the latest global hepatitis data and how we can accelerate action.
Watch back the webinar here: https://bit.ly/4vZCQg0
Download the briefing: https://bit.ly/4y45pdA
July 9, 2026 at 3:02 PM
Missed our first #WorldHepatitisDay webinar?
Watch it back and download our new community briefing to understand the latest global hepatitis data and how we can accelerate action.
Watch back the webinar here: https://bit.ly/4vZCQg0
Download the briefing: https://bit.ly/4y45pdA
Watch it back and download our new community briefing to understand the latest global hepatitis data and how we can accelerate action.
Watch back the webinar here: https://bit.ly/4vZCQg0
Download the briefing: https://bit.ly/4y45pdA
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
#MaPaCi2026, Tg Mures
Multidisciplinary care begins by seeing the person beyond the diagnosis. For people living with viral hepatitis or HIV, trust and reducing stigma are essential parts of care.
Medicine is strongest when knowledge, compassion, and collaboration come together.
#WEEPIFoundation
Multidisciplinary care begins by seeing the person beyond the diagnosis. For people living with viral hepatitis or HIV, trust and reducing stigma are essential parts of care.
Medicine is strongest when knowledge, compassion, and collaboration come together.
#WEEPIFoundation
July 9, 2026 at 6:34 PM
#MaPaCi2026, Tg Mures
Multidisciplinary care begins by seeing the person beyond the diagnosis. For people living with viral hepatitis or HIV, trust and reducing stigma are essential parts of care.
Medicine is strongest when knowledge, compassion, and collaboration come together.
#WEEPIFoundation
Multidisciplinary care begins by seeing the person beyond the diagnosis. For people living with viral hepatitis or HIV, trust and reducing stigma are essential parts of care.
Medicine is strongest when knowledge, compassion, and collaboration come together.
#WEEPIFoundation
#ID are major challenges in pregnancy, with potential consequences across generations. As co-organizer of the @escmid.bsky.social course Two Lives at Risk, @esgvh.bsky.social proudly spotlights #ViralHepatitis in pregnancy: maternal-fetal health&transmission prevention.
@oana-sandulescu.bsky.social
@oana-sandulescu.bsky.social
June 12, 2026 at 9:22 AM
#ID are major challenges in pregnancy, with potential consequences across generations. As co-organizer of the @escmid.bsky.social course Two Lives at Risk, @esgvh.bsky.social proudly spotlights #ViralHepatitis in pregnancy: maternal-fetal health&transmission prevention.
@oana-sandulescu.bsky.social
@oana-sandulescu.bsky.social
One week left to register for the @escmid.bsky.social course: "Navigating infectious diseases in pregnancy", proudly supported by @esgvh.bsky.social.
Keynote lectures from distinguished experts: @oana-sandulescu.bsky.social, Gülşen Özkaya Şahin, Heli Harvala.
Register at the link:
lnkd.in/dadZHyBA
Keynote lectures from distinguished experts: @oana-sandulescu.bsky.social, Gülşen Özkaya Şahin, Heli Harvala.
Register at the link:
lnkd.in/dadZHyBA
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
May 21, 2026 at 3:41 PM
One week left to register for the @escmid.bsky.social course: "Navigating infectious diseases in pregnancy", proudly supported by @esgvh.bsky.social.
Keynote lectures from distinguished experts: @oana-sandulescu.bsky.social, Gülşen Özkaya Şahin, Heli Harvala.
Register at the link:
lnkd.in/dadZHyBA
Keynote lectures from distinguished experts: @oana-sandulescu.bsky.social, Gülşen Özkaya Şahin, Heli Harvala.
Register at the link:
lnkd.in/dadZHyBA
#ESGVH is proud to organize the #HIV Advanced Training Forum 2026 in Bucharest, led by Prof. @oana-sandulescu.bsky.social
& Assoc. Prof. Juan Ambrosioni.
A 2-day course empowering early-career clinicians with practical, evidence-based HIV care.
@eacsociety.bsky.social
@escmid.bsky.social
& Assoc. Prof. Juan Ambrosioni.
A 2-day course empowering early-career clinicians with practical, evidence-based HIV care.
@eacsociety.bsky.social
@escmid.bsky.social
HIV experts from 🇷🇴, 🇳🇱, 🇪🇸, 🇩🇪, 🇬🇧, 🇵🇱 gather in RO for the HIV Advanced Training Forum.
International program for young clinicians, endorsed by leading ID organizations.
Proud to share knowledge, connect and support the next generation shaping HIV care.
@eacsociety.bsky.social @escmid.bsky.social
International program for young clinicians, endorsed by leading ID organizations.
Proud to share knowledge, connect and support the next generation shaping HIV care.
@eacsociety.bsky.social @escmid.bsky.social
March 25, 2026 at 2:36 PM
#ESGVH is proud to organize the #HIV Advanced Training Forum 2026 in Bucharest, led by Prof. @oana-sandulescu.bsky.social
& Assoc. Prof. Juan Ambrosioni.
A 2-day course empowering early-career clinicians with practical, evidence-based HIV care.
@eacsociety.bsky.social
@escmid.bsky.social
& Assoc. Prof. Juan Ambrosioni.
A 2-day course empowering early-career clinicians with practical, evidence-based HIV care.
@eacsociety.bsky.social
@escmid.bsky.social
Our collaborative webinar @esgvh.bsky.social and #UCHID is starting now!
Our Chair, Prof @oana-sandulescu.bsky.social will talk about Rethinking priorities for viral hepatitis management.
Today at 11.00 CET!
Registration is free:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
Our Chair, Prof @oana-sandulescu.bsky.social will talk about Rethinking priorities for viral hepatitis management.
Today at 11.00 CET!
Registration is free:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
Sign In | Zoom
Sign in to your Zoom account to join a meeting, update your profile, change your settings, and more!
https://us06web.zoom.us/webinar/regist…
March 5, 2026 at 10:10 AM
Our collaborative webinar @esgvh.bsky.social and #UCHID is starting now!
Our Chair, Prof @oana-sandulescu.bsky.social will talk about Rethinking priorities for viral hepatitis management.
Today at 11.00 CET!
Registration is free:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
Our Chair, Prof @oana-sandulescu.bsky.social will talk about Rethinking priorities for viral hepatitis management.
Today at 11.00 CET!
Registration is free:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
For 3 days, 🇷🇴 Romania was an international hub for #IPC training, part of the #EUCIC certificate
Participants from 10 countries came together: 🇬🇧 🇩🇪 🇮🇹 🇪🇸 🇸🇮 🇧🇦 🇲🇹 🇹🇷 🇰🇷 🇷🇼 to explore how molecular&bioinformatics tools support surveillance and improve patient safety
@escmid.bsky.social
@eucic.bsky.social
Participants from 10 countries came together: 🇬🇧 🇩🇪 🇮🇹 🇪🇸 🇸🇮 🇧🇦 🇲🇹 🇹🇷 🇰🇷 🇷🇼 to explore how molecular&bioinformatics tools support surveillance and improve patient safety
@escmid.bsky.social
@eucic.bsky.social
February 7, 2026 at 8:23 AM
For 3 days, 🇷🇴 Romania was an international hub for #IPC training, part of the #EUCIC certificate
Participants from 10 countries came together: 🇬🇧 🇩🇪 🇮🇹 🇪🇸 🇸🇮 🇧🇦 🇲🇹 🇹🇷 🇰🇷 🇷🇼 to explore how molecular&bioinformatics tools support surveillance and improve patient safety
@escmid.bsky.social
@eucic.bsky.social
Participants from 10 countries came together: 🇬🇧 🇩🇪 🇮🇹 🇪🇸 🇸🇮 🇧🇦 🇲🇹 🇹🇷 🇰🇷 🇷🇼 to explore how molecular&bioinformatics tools support surveillance and improve patient safety
@escmid.bsky.social
@eucic.bsky.social
Delighted to partner with #UCHID for this impactful webinar on Treatment for all in HBV.
#ESGVH is represented by our Chair, Prof @oana-sandulescu.bsky.social, and EC members Prof Nabil, Assoc Prof Hasanoglu.
📅 March 5, 11 PM CET
🔗 Register:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
#ESGVH is represented by our Chair, Prof @oana-sandulescu.bsky.social, and EC members Prof Nabil, Assoc Prof Hasanoglu.
📅 March 5, 11 PM CET
🔗 Register:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
February 6, 2026 at 2:13 PM
Delighted to partner with #UCHID for this impactful webinar on Treatment for all in HBV.
#ESGVH is represented by our Chair, Prof @oana-sandulescu.bsky.social, and EC members Prof Nabil, Assoc Prof Hasanoglu.
📅 March 5, 11 PM CET
🔗 Register:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
#ESGVH is represented by our Chair, Prof @oana-sandulescu.bsky.social, and EC members Prof Nabil, Assoc Prof Hasanoglu.
📅 March 5, 11 PM CET
🔗 Register:
us06web.zoom.us/webinar/regi...
@escmid.bsky.social
📢 Join us for a #HepDelta webinar by world class speakers: #ESGVH 🤝 #SOLDA
Hepatitis Delta: Challenges in Diagnosis & Management
💻 Online, today ⏰ 11 a.m. CET
🔗 Register for free: lnkd.in/g5AXFGdv
#WebSymposium #ViralHepatitis
@esgvh.bsky.social
@escmid.bsky.social
@oana-sandulescu.bsky.social
Hepatitis Delta: Challenges in Diagnosis & Management
💻 Online, today ⏰ 11 a.m. CET
🔗 Register for free: lnkd.in/g5AXFGdv
#WebSymposium #ViralHepatitis
@esgvh.bsky.social
@escmid.bsky.social
@oana-sandulescu.bsky.social
December 18, 2025 at 8:30 AM
📢 Join us for a #HepDelta webinar by world class speakers: #ESGVH 🤝 #SOLDA
Hepatitis Delta: Challenges in Diagnosis & Management
💻 Online, today ⏰ 11 a.m. CET
🔗 Register for free: lnkd.in/g5AXFGdv
#WebSymposium #ViralHepatitis
@esgvh.bsky.social
@escmid.bsky.social
@oana-sandulescu.bsky.social
Hepatitis Delta: Challenges in Diagnosis & Management
💻 Online, today ⏰ 11 a.m. CET
🔗 Register for free: lnkd.in/g5AXFGdv
#WebSymposium #ViralHepatitis
@esgvh.bsky.social
@escmid.bsky.social
@oana-sandulescu.bsky.social
#ESGVH message for #HepTestWeek 25:
Testing saves lives. Awareness drives change. Action moves us forward.
🩺 Early diagnosis = timely treatment
🤝 Normalize testing, reduce stigma
🌍 Elimination is possible if we act now
@escmid.bsky.social @worldhepalliance.bsky.social @oana-sandulescu.bsky.social
Testing saves lives. Awareness drives change. Action moves us forward.
🩺 Early diagnosis = timely treatment
🤝 Normalize testing, reduce stigma
🌍 Elimination is possible if we act now
@escmid.bsky.social @worldhepalliance.bsky.social @oana-sandulescu.bsky.social
November 23, 2025 at 10:20 AM
#ESGVH message for #HepTestWeek 25:
Testing saves lives. Awareness drives change. Action moves us forward.
🩺 Early diagnosis = timely treatment
🤝 Normalize testing, reduce stigma
🌍 Elimination is possible if we act now
@escmid.bsky.social @worldhepalliance.bsky.social @oana-sandulescu.bsky.social
Testing saves lives. Awareness drives change. Action moves us forward.
🩺 Early diagnosis = timely treatment
🤝 Normalize testing, reduce stigma
🌍 Elimination is possible if we act now
@escmid.bsky.social @worldhepalliance.bsky.social @oana-sandulescu.bsky.social
🌍 Proud of #ESGVH Chair Prof @oana-sandulescu.bsky.social for her inspiring role at #EACS2025 in Paris! 🎓🎤 Now Vice Chair of #YING, she’s advancing education & building bridges 🌉 between #ESCMID 🦠 and #EACS 🧬 for a healthier, more connected future 🌐💫
@escmid.bsky.social
@eacsociety.bsky.social
@escmid.bsky.social
@eacsociety.bsky.social
October 19, 2025 at 9:13 AM
🌍 Proud of #ESGVH Chair Prof @oana-sandulescu.bsky.social for her inspiring role at #EACS2025 in Paris! 🎓🎤 Now Vice Chair of #YING, she’s advancing education & building bridges 🌉 between #ESCMID 🦠 and #EACS 🧬 for a healthier, more connected future 🌐💫
@escmid.bsky.social
@eacsociety.bsky.social
@escmid.bsky.social
@eacsociety.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
Also at #EACS2025 🇫🇷✨
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
October 18, 2025 at 7:55 PM
Also at #EACS2025 🇫🇷✨
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
Privileged to speak on advancing #HIV #PrEP equity 🌍 and improving access 💉💊
#EACS2025 was not only a platform for learning 📚 and collaboration 🙌 but also a chance to reconnect with friends 🤗
Grateful to be part of this passionate community 🤍
@eacsociety.bsky.social
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
#EACS2025 🇫🇷✨
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
October 18, 2025 at 7:52 PM
#EACS2025 🇫🇷✨
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
It was a pleasure co-organizing the Educational Course with the incredible #YING Faculty.
Excited to step in as #EACS #YING Vice Chair and work with our new Chair Jose Bernardino following in the steps of @tristanjbarber.bsky.social 🙌
@eacsociety.bsky.social
#HIV #GlobalHealth
Reposted by ESGVH (ESCMID Study Group for Viral Hepatitis)
#EACS2025- Oana Sandulescu is talking about advancing #PrEP equity across #Europe by integrating policy, community and clinical approaches, integrating PrEP delivery, reaching underserved populations, simplifying access and supporting community-led and peer-based models.
October 16, 2025 at 11:18 AM